, /PRNewswire/ -- The Florida Society of Clinical Oncology (FLASCO), a statewide organization dedicated to facilitating collaboration and education among oncology professionals, is pleased to share a new white paper exploring the transformative potential of bispecific antibodies (BsAbs) in lymphoma treatment. Developed by thought leaders from across Florida, the paper offers actionable recommendations for wider adoption throughout the state. With demonstrated success in clinical trials, BsAbs represent a significant advancement in cancer care.